JBGS JBG SMITH delivers far stronger than expected Q4 2025 EPS but shares edge down slightly today TBB ATT Inc reports Q1 2026 EPS of 057 dollars shares climb 023 percent in todays trading Regeneron Pharmaceuticals REGN Unveils C5 Complement Pipeline Strategy But Execution Risks Cap NearTerm Upside